Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis

Chemotherapy

Volumn 55, Issue 3, 2009, Pages 145-154

  Han, Jung Ho ^a   Park, Chul Kee ^b,c   Lee, Se Hoon ^b,c   Kim, Chae Yong ^a   Kim, Dong Wan ^b,c   Paek, Sun Ha ^b,c   Kim, Dong Gyu ^b   Heo, Dae Seog ^b,c   Kim, Il Han ^b,c   Jung, Hee Won ^b,d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

ACNU; Cisplatin; Glioblastoma; Preradiation chemotherapy; Survival

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; LOMUSTINE; NIMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DYSPEPSIA; DYSURIA; FEBRILE NEUTROPENIA; FEMALE; GLIOBLASTOMA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PANCYTOPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DACARBAZINE; DRUG THERAPY, COMBINATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NIMUSTINE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 65449137981     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214142     Document Type: Article

References (33)

1. Mineo JF, Bordron A, Baroncini M, Ramirez C, Maurage CA, Blond S, Dam-Hieu P: Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir 2007; 149: 245-253.
2. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgauer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A: Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 2003; 98: 2678-2686.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-996.
4. Guensberg P, Wacheck V, Lucas T, Monia B, Pehamberger H, Eichler HG, Jansen B: BclxL antisense oligonucleotides chemosensitize human glioblastoma cells. Chemotherapy 2002; 48:189-195.
5. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and metaanalysis of individual patient data from 12 randomised trials. Lancet 2002; 359:1011-1018.
6. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J 2nd, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303:1323-1329.
7. Choi IS, Lee SH, Kim TY, Bang JS, Paek SH, Kim S, Kim IH, Heo DS, Bang YJ, Kim DG, Jung HW, Kim NK: Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol 20 02; 60: 17 1-176 .
8. Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K, Fukui T, Nakashima Y, Ishikawa M, Hashimoto N: Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group. J Neurosurg 2006; 105:385-391.
9. Paoletti P, Butti G, Knerich R, Gaetani P, Assietti R: Chemotherapy for malignant gliomas of the brain: a review of ten-years experience. Acta Neurochir 1990; 103:35-46.
10. Gwak HS, Youn SM, Kwon AH, Lee SH, Kim JH, Rhee CH: ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study. J Neurooncol 2005; 75:173-180.
11. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK: Glioblastoma; in Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon, IARC Press, 2000.
12. Grossman SA, O'Neill A, Grunnet M, Mehta M, Pearlman JL, Wagner H, Gilbert M, Newton HB, Hellman R: Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 2003; 21: 1485-1491.
13. Grossman SA, Wharam M, Sheidler V, Kleinberg L, Zeltzman M, Yue N, Piantadosi S: Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol 1997; 15: 2596-2603.
14. Norman D, Stevens EA, Wing SD, Levin V, Newton TH: Quantitative aspects of contrast enhancement in cranial computed tomography. Radiology 1978; 129:683-688.
15. Gerosa MA, Rosenblum ML, Stevanoni G, Licata C, Della Corte V, Marcon C, Bricolo A, Tridente G: In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas. Acta Neurol Scand 1986; 73: 66-70.
16. Gilbert M, O'Neill A, Grossman S, Grunnet M, Mehta M, Jubelirer S, Hellman R: A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393). J Neurooncol 2000; 47: 14 5 -1 5 2 .
17. Iwadate Y, Namba H, Sueyoshi K: Intra-arte-rial ACNU and cisplatin chemotherapy for the treatment of glioblastoma multiforme. Neurol Med Chir 1995; 35:598-603.
18. Kochii M, Kitamura I, Goto T, Nishi T, Takeshima H, Saito Y, Yamamoto K, Kimura T, Kino T, Tada K, Shiraishi S, Uemura S, Iwasaki T, Kuratsu J, Ushio Y: Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma. J Neurooncol 2000;49:63-70.
19. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, et al: Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 1986; 64: 53-57.
20. Wakui A: Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas (in Japanese). Gan To Kagaku Ryoho 1982; 9:1327-1338.
21. Shimizu K, Ushio Y, Hayakawa T, Mogami H: Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats. Cancer Res 1980; 40: 1341-1343.
22. Weller M, Muller B, Koch R, Bamberg M, Krauseneck P: Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 2003; 21:3276-3284.
23. Yung WK, Janus TJ, Maor M, Feun LG: Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas. J Neurooncol 1992; 12:131-135.
24. Volk PE DW: Radiation injury of the brain, Am J Neurol Radiol 1991; 12:45-62.
25. Airley RE, Mobasheri A: Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007; 53:233-256.
26. Irwin C, Hunn M, Purdie G, Hamilton D: Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 2007; 85: 339 -3 4 3 .
27. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G: Long-term survival with glioblastoma multiforme. Brain 2007; 130:2596-2606.
28. Senger D, Cairncross JG, Forsyth PA: Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype? Cancer J 2003; 9:214-221.
29. Davis FG, Freels S, Grutsch J, Barlas S, Brem S: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88: 1-10 .
30. Salcman M, Scholtz H, Kaplan RS, Kulik S: Long-term survival in patients with malignant astrocytoma. Neurosurgery 1994; 34: 213-219; discussion 9-20.
31. Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993; 32: 716-720; discussion 20.
32. van den Bent MJ, Hegi ME, Stupp R: Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 2006; 42:582-588.
33. Reardon DA, Rich JN, Friedman HS, Bigner DD: Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 2006; 24: 1253-1265.